IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

venBio Partners L.P.

Q2 2018 Holdings

Filed 2018-08-14 | 4 holdings | $96.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Apellis Pharmaceuticals, IncCOM037530106$72.5K3,294,65474.8%
Verona Pharma PLC(VRNA)SPONSORED ADS925050106$12.0K875,00012.3%
Menlo Therapeutics Inc.COM586858102$11.9K1,461,55212.2%
Nabriva Therapeutics PLCSHSG63637105$619177,9570.6%